Home   /   Annual Meeting   /   EASD 2026   /   Scientific Submissions

Scientific Submissions

Abstract and Session Proposal Submission are now open and will close on 1 and 27 April 2026 respectively.

Session Proposal Submission

The Scientific Programme at the EASD Annual Meeting is set up by the Scientific Programme Committee chaired by the EASD Honorary Secretary. The Scientific Programme Committee welcomes additional external symposia suggestions. These will be discussed and prioritised by the Scientific Programme Committee.

The EASD Session Proposal Submission available via MyEASD will close on the deadline 27 April 2026 at 18:00hrs CEST.

Please note that submission of any proposal does not imply any commitment from EASD. Information about acceptance/rejection will be sent to the submitter’s e-mail address by mid-June. If accepted, the session duration of your suggestion will be defined by the Scientific Programme Committee; accepted suggestions may also be edited to avoid overlaps in the programme. All proposals accepted by the EASD Scientific Programme Committee will be part of the final official Scientific Programme of the 62nd EASD Annual Meeting in Milan.

Abstract Submission

The EASD Abstract Submission System available via MyEASD will close on the deadline 1 April 2026 at 18:00hrs CEST.

All communications must be delivered in English. There is no simultaneous translation.

Abstracts can only be submitted online and must be submitted BEFORE 1 APRIL 2026 18:00hrs CEST. THIS DEADLINE WILL BE STRICTLY ENFORCED, as will be the regulations given below. The presenting (= first named) author will be notified when the abstracts with the status "complete" are forwarded for anonymous review.

The following is an overview of the abstract submission process. Please read carefully the: DETAILED ABSTRACT SUBMISSION GUIDELINES before you begin the abstract submission process.

It is not permitted to submit work that has been published and/or is likely to be published before the EASD Abstract submission deadline (1 April 2026, 18:00hrs. CEST). The Programme Committee has the right to remove an abstract if this contains data that has already been published. However, EASD accepts the submission of abstracts that have been presented in recent months at local or national diabetes meetings (e.g. ADA, DDG). An author submitting or presenting work that has been published in a journal before the EASD Abstract submission deadline (1 April 2026, 18:00hrs CEST) will be banned from presenting data at the EASD Meetings for three years.

Abstracts submitted on Human Studies:

The box must be marked stating that the study has been reviewed by the Local Ethics Committee and that it has therefore been performed in accordance with the ethical standards laid down in the Helsinki Declaration (see World Medical Association: www.wma.net).

Abstracts submitted on Animal Studies:

The box must be marked stating that the study has been carried out along the “Principles of laboratory animal care” (NIH Publication no. 85-23, revised 1985) and according to the national law, if applicable.

Selection of abstracts for the Scientific Programme is made anonymously. THE ABSTRACT MUST BE SUBMITTED as follows:

There is no limit to the number of abstracts an author may submit; however, an author may only serve as the presenting author on two submissions. It is the authors’ responsibility to designate a new presenter for presentation scheduling conflicts that arise. If accepted, the presenter must be a co-author listed on the abstract at the time of submission.

It is mandatory that the presenting author of any abstract accepted for presentation or discussion attends the EASD Annual Meeting 2026 in Milan to present and discuss his/her paper. Failure to do so, without prior or adequate explanation sent to the EASD Office by e-mail, may result in:

  • the author or the institution being banned from presenting abstracts for the next three years,
  • the accepted abstract being removed from the Abstract Volume.

Abstracts are welcome from non-members of EASD. Please refer to the Registration section of this General Information, regarding the date by which authors must become members of EASD in order to qualify for preferential registration fees. These regulations will be strictly enforced.

The abstract must be submitted in English. New submitters/authors should create a MyEASD account. With these access credentials, they can revise the submission as often as required, make changes, additions, amendments, change/add/delete authors, copy special characters easily into the text, re-write the abstract or copy and paste the text in the corresponding boxes. All this is possible until the Abstract Submission Deadline: 1 April 2026 18:00hrs CEST. After this date the submission site will be closed. IMPORTANT!: Always double check that the “complete” status of your submitted abstract has NOT been affected after having edited it.

CHANGES TO THE CONTENT AND/OR THE AUTHOR BLOCK OF THE SUBMITTED ABSTRACT WILL NOT BE ACCEPTED after the submission deadline.

Your abstract submission must adhere the following structure:
  • The maximum number of characters is 3,200 (excl. spaces) including the title and the author block. The title should be short (maximum 170 characters).
  • Please enter your name and the names of co-authors as given in the example below. Start each name with a capital letter and continue in lower case, do not enter names/affiliations all in capital letters.
    First Name: John
    2nd Initial:  J
    3rd Initial:   R
    Last Name: Macleod
  • The abstract must be structured. Enter each section into the corresponding text field with the provided sub-headings in bold (Background and aims, Materials and methods, Results and Conclusion). The abstract structuring words are fixed for each abstract text box. One or two sentences should describe the methods, and any aspects of methodology (e.g. use of control groups, randomisation, patient selection, assay variation). The sentences stating the results must include hard data, including statistical analysis. The abstract requires solid data, i.e. n, p-values and confidence intervals if appropriate. No systematic reviews. No study protocols. Only original studies.
  • It is allowed to include only one table OR one graph to your abstract, but 400 characters will be deducted from the maximum number of characters allowed. Tables must be uploaded as an image; so you must create your table and convert it into an image in order to include it in your abstract. You can edit your table or graph and then replace it, or delete it until the submission deadline of 1 April 2025, 18:00hrs CEST. Do not enter both (a table and a graph) in the same image file; also, do not create and upload multi panel images (a maximum of two panels is allowed). When creating a table, do not exceed a number of 10 columns and 12 rows with a maximum of 1 line per row!
  • References are not allowed.
  • For drugs exclusively generic names should be used (no trademarks).
  • A list of approved abbreviations and units of expression for use without definition appears in Diabetologia.
  • Grant/Support information must be entered in its designated field, not in the abstract body.
  • Where applicable, the Clinical Trial Registration Number must be entered into its designated field, not in the abstract body.
  • Only one keyword can be selected.
  • Abstracts CANNOT be submitted as an e-mail attachment.

Once all submission steps have been successfully completed and the abstract deadline has passed, a notification confirming the final version of the abstract submission will be posted on the presenting author’s Scientific Submission portal (accessible by loging into MyEASD). All notifications will be posted ONLY on the presenting = first named author’s Scientific Submission portal, the name, middle name, last name and e-mail contact used during the submission process must match any existing EASD membership and/or MyEASD account (only one e-mail address per presenting = first named author).

In case of questions, or if no notification confirming the final version of the abstract submission has been received by 14 April 2026, please contact the EASD office: abstracts@easd.org.

Keywords

One keyword from the list available here must be selected for the submission.

Scientific Programme Committee

Preference for oral presentation or short oral discussion is not possible. The Scientific Programme Committee allocates the accepted abstracts to either an oral presentation or a short oral discussion session. The Scientific Programme Committee Members will meet in May 2026 and have the absolute right to accept or reject abstracts. Their decision is final. Only accepted abstracts will be published in the Abstract Volume. The Scientific Programme Committee’s decision will be posted ONLY on the presenting = first named author’s Scientific Submission portal, the first name, last name and e-mail contact used during the submission process must match any existing EASD membership and/or MyEASD account (only one e-mail address per presenting = first named author).

Short Oral Discussions and Oral Presentations

Short Oral Discussions rank equally with Oral Presentations at the EASD Annual Meeting. Oral and Short Oral Presentations during the EASD Annual Meeting will be delivered live; they will also be made available on the EASD Media Centre.

Short Oral Discussions

A short PowerPoint presentation without audio must be uploaded to the EASD presentation management platform by the indicated deadline prior to the start of the Annual Meeting. Further details will be communicated to the presenting authors by means of a notification of acceptance posted ONLY on the presenting = first named author’s Scientific Submission portal (the first name, last name and e-mail contact used during the submission process must match any existing EASD membership and/or MyEASD account (only one e-mail address per presenting = first named author).

Oral Presentations

PowerPoint presentation will be available for Oral Presentations. Further details on presentation will be communicated to the presenting authors by means of a notification of acceptance ONLY on the presenting = first named author’s Scientific Submission portal (the first name, last name and e-mail contact used during the submission process must match any existing EASD membership and/or MyEASD account (only one e-mail address per presenting = first named author).

Publication of Abstracts

Accepted abstracts will be published in the Abstract Volume, a supplement issue of Diabetologia, the journal of the EASD. Furthermore, abstracts accepted for presentation and discussion will be published on the Association’s website www.easd.org from 1 July 2026.

Log in to MyEASD to start or edit your scientific submissions for EASD 2026

MyEASD

Late-breaking Abstract Submission 2026

The late-breaking Abstract Submission System will be available via MyEASD from 3 June and will close on the deadline 17 June at 18:00hrs CEST.

The late-breaking abstract deadline is not an extension of the abstract submission deadline.